| RS1569304218 |
GLA
|
Health Risk |
Likely pathogenic |
— |
| RS1569304221 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1569304774 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1569304851 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1569304867 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569304886 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569304898 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Cardiovascular phenotype |
| RS1569304920 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1569305431 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS1569306022 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1569306036 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569306108 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569306168 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS1569306181 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1569306667 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS1569306724 |
CASK
|
Health Risk |
Pathogenic |
Intellectual disability, CASK-related |
| RS1569308524 |
MYO18B
|
Health Risk |
Likely pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS1569308571 |
SMPX
|
Health Risk |
Pathogenic |
X-linked deafness, X-linked deafness |
| RS1569309449 |
RLIM
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 61 |
| RS1569309459 |
RLIM
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 61 |
| RS1569309460 |
RLIM
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 61 |
| RS1569309474 |
RLIM
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 61 |
| RS1569309484 |
RLIM
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 61 |
| RS1569309694 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1569309776 |
RLIM
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 61 |
| RS1569309816 |
RLIM
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 61 |
| RS1569310039 |
RLIM
|
Health Risk |
Likely pathogenic |
— |
| RS1569310232 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS1569310288 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS1569310542 |
PHKA2
|
Health Risk |
Likely pathogenic |
— |
| RS1569312133 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1569314119 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1569314152 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569314471 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569314475 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569314508 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS1569314809 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569314907 |
WDR4
|
Health Risk |
Pathogenic |
Galloway-Mowat syndrome 6, Galloway-Mowat syndrome 6 |
| RS1569315042 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569315156 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569315169 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569315186 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1569315231 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569315381 |
PCDH19
|
Health Risk |
Pathogenic |
— |
| RS1569315403 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569315508 |
PCDH19
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569315842 |
PCDH19
|
Health Risk |
Likely pathogenic |
Bilateral tonic-clonic seizure, Bilateral tonic-clonic seizure |
| RS1569315869 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS1569315876 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569315950 |
PCDH19
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569316056 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1569316085 |
HDAC8
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 1 |
| RS1569317995 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS1569318004 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS1569319773 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS1569321518 |
ZDHHC9
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Raymond type, Syndromic X-linked intellectual disability Raymond type |
| RS1569322834 |
SYN1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569324457 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1569333062 |
F9
|
Health Risk |
Likely pathogenic |
— |
| RS1569333361 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1569334260 |
PHF6
|
Health Risk |
Likely pathogenic |
Borjeson-Forssman-Lehmann syndrome, Borjeson-Forssman-Lehmann syndrome |
| RS1569334937 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS1569335056 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS1569335080 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1569335135 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS1569335193 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked intellectual disability, Cantagrel type |
| RS1569335235 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS1569335265 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS1569335460 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1569335485 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS1569335666 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS1569335738 |
NEXMIF
|
Health Risk |
Pathogenic |
Thyroid cancer, nonmedullary |
| RS1569335877 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS1569335893 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS1569336024 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS1569337176 |
ASXL1
|
Health Risk |
Likely pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1569337452 |
ASXL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1569339085 |
ASXL1
|
Health Risk |
Pathogenic |
Bohring-Opitz syndrome, Bohring-Opitz syndrome |
| RS1569339879 |
GPC4
|
Health Risk |
Pathogenic |
Keipert syndrome, Keipert syndrome |
| RS1569341521 |
GPC4
|
Health Risk |
Pathogenic |
Keipert syndrome, Keipert syndrome |
| RS1569343210 |
PHF6
|
Health Risk |
Likely pathogenic |
— |
| RS1569344469 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1569345504 |
ZIC3
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1569345723 |
ZIC3
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1569345742 |
ZIC3
|
Health Risk |
Pathogenic |
Heterotaxy, visceral |
| RS1569350501 |
CASK
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Syndromic X-linked intellectual disability Najm type |
| RS1569350993 |
POLA1
|
Health Risk |
Pathogenic |
X-linked intellectual disability, van Esch type |
| RS1569351341 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1569351529 |
SMS
|
Health Risk |
Likely pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS1569351534 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1569351907 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1569354918 |
HPRT1
|
Health Risk |
Likely pathogenic |
Lesch-Nyhan syndrome, HPRT1-related disorder |
| RS1569355102 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1569356550 |
MIR6857;SMC1A
|
Health Risk |
Pathogenic/Likely pathogenic |
SMC1A-related disorder, Congenital muscular hypertrophy-cerebral syndrome |
| RS1569356555 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Developmental and epileptic encephalopathy |
| RS1569356968 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1569358628 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1569358774 |
SMC1A
|
Health Risk |
Likely pathogenic |
— |
| RS1569359021 |
HPRT1
|
Health Risk |
Pathogenic |
— |
| RS1569359048 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |